167 related articles for article (PubMed ID: 30825834)
1. The anti-fibrotic role of mast cells in the liver is mediated by HLA-G and interaction with hepatic stellate cells.
Amiot L; Vu N; Drenou B; Scrofani M; Chalin A; Devisme C; Samson M
Cytokine; 2019 May; 117():50-58. PubMed ID: 30825834
[TBL] [Abstract][Full Text] [Related]
2. Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis.
Amiot L; Vu N; Rauch M; L'Helgoualc'h A; Chalmel F; Gascan H; Turlin B; Guyader D; Samson M
J Hepatol; 2014 Feb; 60(2):245-52. PubMed ID: 24036009
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice.
Hara M; Kono H; Furuya S; Hirayama K; Tsuchiya M; Fujii H
J Surg Res; 2013 Aug; 183(2):574-82. PubMed ID: 23578751
[TBL] [Abstract][Full Text] [Related]
4. Succinate induces hepatic fibrogenesis by promoting activation, proliferation, and migration, and inhibiting apoptosis of hepatic stellate cells.
Park SY; Le CT; Sung KY; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Feb; 496(2):673-678. PubMed ID: 29366478
[TBL] [Abstract][Full Text] [Related]
5. Anti-fibrotic effect of thymoquinone on hepatic stellate cells.
Ghazwani M; Zhang Y; Gao X; Fan J; Li J; Li S
Phytomedicine; 2014 Feb; 21(3):254-60. PubMed ID: 24182989
[TBL] [Abstract][Full Text] [Related]
6. Human and rat hepatic stellate cells produce stem cell factor: a possible mechanism for mast cell recruitment in liver fibrosis.
Gaça MD; Pickering JA; Arthur MJ; Benyon RC
J Hepatol; 1999 May; 30(5):850-8. PubMed ID: 10365812
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
[TBL] [Abstract][Full Text] [Related]
9. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy.
Wang X; Zhang W; Zeng S; Wang L; Wang B
Acta Biomater; 2024 Feb; 175():262-278. PubMed ID: 38141933
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
[TBL] [Abstract][Full Text] [Related]
11. Hepatic stellate cells secreting WFA
Bekki Y; Yoshizumi T; Shimoda S; Itoh S; Harimoto N; Ikegami T; Kuno A; Narimatsu H; Shirabe K; Maehara Y
J Gastroenterol Hepatol; 2017 Jul; 32(7):1387-1393. PubMed ID: 28008658
[TBL] [Abstract][Full Text] [Related]
12. Gα
Kim KM; Han CY; Kim JY; Cho SS; Kim YS; Koo JH; Lee JM; Lim SC; Kang KW; Kim JS; Hwang SJ; Ki SH; Kim SG
J Hepatol; 2018 Mar; 68(3):493-504. PubMed ID: 29080810
[TBL] [Abstract][Full Text] [Related]
13. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells.
Tan Z; Liu Q; Jiang R; Lv L; Shoto SS; Maillet I; Quesniaux V; Tang J; Zhang W; Sun B; Ryffel B
Cell Mol Immunol; 2018 Apr; 15(4):388-398. PubMed ID: 28194023
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of the Wnt antagonist Dkk2 links the loss of Sept4 and myofibroblastic transformation of hepatic stellate cells.
Yanagida A; Iwaisako K; Hatano E; Taura K; Sato F; Narita M; Nagata H; Asechi H; Uemoto S; Kinoshita M
Biochim Biophys Acta; 2011 Nov; 1812(11):1403-11. PubMed ID: 21763422
[TBL] [Abstract][Full Text] [Related]
16. Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis.
Li Y; Lua I; French SW; Asahina K
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(4):G262-72. PubMed ID: 26702136
[TBL] [Abstract][Full Text] [Related]
17. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
[TBL] [Abstract][Full Text] [Related]
18. IL-17 and TNF-α co-operation contributes to the proinflammatory response of hepatic stellate cells.
Beringer A; Miossec P
Clin Exp Immunol; 2019 Oct; 198(1):111-120. PubMed ID: 31102558
[TBL] [Abstract][Full Text] [Related]
19. A Deactivation Factor of Fibrogenic Hepatic Stellate Cells Induces Regression of Liver Fibrosis in Mice.
Nakano Y; Kamiya A; Sumiyoshi H; Tsuruya K; Kagawa T; Inagaki Y
Hepatology; 2020 Apr; 71(4):1437-1452. PubMed ID: 31549421
[TBL] [Abstract][Full Text] [Related]
20. Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling.
Li J; Wang Y; Ma M; Jiang S; Zhang X; Zhang Y; Yang X; Xu C; Tian G; Li Q; Wang Y; Zhu L; Nie H; Feng M; Xia Q; Gu J; Xu Q; Zhang Z
EBioMedicine; 2019 Feb; 40():43-55. PubMed ID: 30639416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
